Level Chart

Basic Info

Zoetis Inc (ZTS) - Contract Manufacturing & Human Health Revenue is at a current level of 30.00M, up from 23.00M last quarter and up from 21.00M one year ago. This is a change of 30.43% from last quarter and 42.86% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 30.00M
Latest Period Dec 2025
Last Updated Mar 23 2026, 14:15 EDT
Next Release Apr 15 2026, 08:30 EDT (E)
Average Growth Rate 14.65%
Value from Last Quarter 23.00M
Change from Last Quarter 30.43%
Value from 1 Year Ago 21.00M
Change from 1 Year Ago 42.86%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
December 31, 2025 30.00M
September 30, 2025 23.00M
June 30, 2025 34.00M
March 31, 2025 29.00M
December 31, 2024 21.00M
September 30, 2024 21.00M
June 30, 2024 18.00M
March 31, 2024 20.00M
December 31, 2023 20.00M
September 30, 2023 21.00M
June 30, 2023 20.00M
March 31, 2023 17.00M
December 31, 2022 27.00M
Date Value
September 30, 2022 23.00M
June 30, 2022 18.00M
March 31, 2022 18.00M
December 31, 2021 25.00M
September 30, 2021 21.00M
June 30, 2021 20.00M
March 31, 2021 16.00M
December 31, 2020 23.00M
September 30, 2020 23.00M
June 30, 2020 17.00M
March 31, 2020 20.00M
December 31, 2019 22.00M

Basic Info

Zoetis Inc (ZTS) - Contract Manufacturing & Human Health Revenue is at a current level of 30.00M, up from 23.00M last quarter and up from 21.00M one year ago. This is a change of 30.43% from last quarter and 42.86% from one year ago.

Region United States
Source Fiscal.ai

Data provided via Fiscal.ai

Stats

Last Value 30.00M
Latest Period Dec 2025
Last Updated Mar 23 2026, 14:15 EDT
Next Release Apr 15 2026, 08:30 EDT (E)
Average Growth Rate 14.65%
Value from Last Quarter 23.00M
Change from Last Quarter 30.43%
Value from 1 Year Ago 21.00M
Change from 1 Year Ago 42.86%
Frequency Quarterly
Unit USD
Adjustment N/A
Download Source File

Related Securities

Symbol Name Change %
ZTS Zoetis, Inc. 0.53%